1-(2-furylmethyl)-6-oxo-1,6-dihydropyridazine-3-carboxylic acid, 95.0%, 500mg

1,1,1,3,3,3-Hexafluoro-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propan-2-ol, 98%, 250mg

(R)-8-(1-Acryloylpiperidin-3-yl)-10-(4-phenoxyphenyl)-3,4-dihydropyrazolo[4,3-e]pyrimido[1,2-c]pyrimidin-2(8H)-one (Ibrutinib Impurity), 97%, 50mg

2-[(4-methylphenyl)carbonyl]benzoic acid, 98.0%, 5g

5-amino-2-methoxybenzoic acid, 95.0%, 25g

5-Hydroxyindole, 98.0%, 5g

2-Oxo-1,2,3,4-tetrahydro-quinoline-4-carboxylic acid, 95.0%, 100mg

2-Hexyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 25g

1-(6-Bromopyridin-3-yl)-2-methoxyethan-1-one, 250mg

4-(Trifluoromethyl)benzenecarboximidamide, 98%, 500mg

3-Phenyl-[1,2,4]oxadiazol-5-ol, 95.0%, 25g

Single-channel microliter pipette ROTILABO®, 100 to 1000 µl, 1 piece

N-(3,5-bis((Triisopropylsilyl)oxy)phenyl)-3-hydroxy-2-nitrobenzamide, 95%, 1g